Role:
TP
TechPranee PV
PharmaCorp Ltd

QC & Handoff

Case PV-2026-0142 · Final QC, discrepancy resolution, and handoff package generation

Stage 8 of 8QC in progress
AI Quality Agent findings are suggestions only and remain open until a QC reviewer explicitly accepts or rejects them. This prototype does not perform regulatory submission — integration buttons stage packages only.

QC Checklist

9 pass3 pending0 fail
CheckDescriptionNoteStatusActions
Source article attachedFull-text PDF of the source article is attached to the case record.Reinholt_2026_cardiomab_DILI.pdf attached✓ Pass
Citation completeVancouver-style citation includes authors, title, journal, year, volume, pages.Reinholt M, et al. J Hepatol. 2026;71(3):412–418.✓ Pass
Patients separatedEach identifiable patient in the article is split into a separate case.Single patient in source — no split required.✓ Pass
Four minimum criteria reviewedIdentifiable patient, identifiable reporter, suspect product, and suspected reaction all reviewed by a human.All four confirmed/edited in ICSR Workbench.✓ Pass
Product/event evidence confirmedSource passages supporting product and event identification are linked and verified.Page 3 ¶2 (product), Page 4 ¶1 (event).✓ Pass
Seriousness indicators reviewedSeriousness criteria (hospitalisation, life-threatening, disability, etc.) reviewed and justified.Hospitalisation 9 days — serious.✓ Pass
Day Zero confirmedHuman-confirmed Day Zero date with evidence and (if applicable) correction reason.Awaiting reviewer confirmation in ICSR Workbench.⏳ Pending
Narrative source-supportedEvery narrative sentence is traceable to a source passage; no invented dates, doses, or outcomes.2 flags (missing onset date, conflicting outcome) acknowledged.✓ Pass
Human corrections documentedAll edits to AI-extracted fields are logged with reviewer identity and timestamp.Audit trail shows 3 edits by reviewer TP.✓ Pass
Duplicate search completedCase checked against existing safety database for duplicate patients/products.Duplicate search not yet executed.⏳ Pending
Medical review completedA qualified medical reviewer has reviewed the case narrative and seriousness assessment.Medical reviewer sign-off pending.⏳ Pending
Audit history completeEnd-to-end audit trail from search run → screening → workbench → QC is intact.12 audit entries, no gaps detected.✓ Pass

AI Quality Agent — Discrepancy Panel

🤖 Quality Agent
8 open · 0 accepted · 0 rejected

Findings are suggestions. They remain open until a QC reviewer accepts or rejects each one. Accepted findings flow into the QC record; rejected findings are logged with the rejection.

warningPatient age/sex

Structured data says 64-year-old woman; abstract mentions “female in her seventh decade” — consistent, but verify exact age.

Suggested action: Confirm age against full-text Page 3 ¶2.

warningProduct dose mismatch

Narrative states “Cardiomab 10mg” but Table 2 lists “10 mg/day” — unit formatting differs.

Suggested action: Standardise dose representation to “10 mg, oral, once daily.”

criticalEvent date before exposure

AI extracted an event date of 2026-05-30 but therapy start is reported as “six weeks prior” — chronology implies onset within exposure window, not before. Flagged for verification.

Suggested action: Remove inferred event date; mark as missing until source confirms exact onset.

warningMissing outcome

Outcome field says “Recovering” but Discussion mentions “persistent cholestasis at 6-month follow-up” — outcome not fully resolved.

Suggested action: Set outcome to “Recovering/Not recovered” and add follow-up note.

criticalSeriousness inconsistency

Seriousness marked as “required/prolonged hospitalisation” but hospitalisation duration not explicitly stated as > limits — verify against local criteria.

Suggested action: Confirm hospitalisation duration (9 days) meets serious criteria threshold.

warningNarrative vs structured data

Narrative mentions “R-value >5” (interpretation) but structured reactions field lists only “Acute liver injury.”

Suggested action: Add “drug-induced liver injury (R-value >5)” to structured reactions.

infoUnconfirmed AI-extracted fields

Two case information fields (concomitant products, country) remain unconfirmed by the reviewer.

Suggested action: Return to ICSR Workbench and confirm or edit these fields.

warningMissing source citation

Company comments field has no source citation — reviewer-entered text should note provenance.

Suggested action: Add citation or mark as internal company comment (non-sourced).

Handoff Package Generation

Structured literature case summary assembling: source article, citation, patient data, four-criteria assessment, draft narrative, seriousness indicators, Day Zero evidence, human review record, and QC record.

Cannot generate package until all QC checks pass and all discrepancies are resolved.
Source article
Reinholt_2026_cardiomab_DILI.pdf
Citation
Reinholt M, et al. J Hepatol 2026
Patient data
Female, 64y, medical history
Four-criteria assessment
4/4 confirmed
Draft narrative
Source-linked, 2 flags ack.
Seriousness indicators
Hospitalisation 9 days
Day Zero evidence!
Pending confirmation
Human review record
3 edits, reviewer TP
QC record!
9/12 checks, 0 discrepancies

Safety System Integration

Integration placeholders for downstream safety databases. No regulatory submission is performed in this prototype — buttons only stage a package locally.

Integration status
Not sent
Prototype
QC: 9/12 checks pass · 8 discrepancies open · Package not generated
← Back to ICSR Workbench